date,title,source
Oct-26-18,"Eidos Therapeutics Receives Positive Opinion for Orphan Designation from the European Medicines Agency for AG10, a Potent Oral Stabilizer for the Treatment of Transthyretin Amyloidosis",GlobeNewswire
Oct-29-18,Eidos Therapeutics to Host Conference Call and Webcast to Discuss Phase 2 Clinical Trial Results,GlobeNewswire
Nov-14-18,Eidos Therapeutics to Present at Two Upcoming Investor Conferences,GlobeNewswire
Nov-21-18,"Factors of Influence in 2018, Key Indicators and Opportunity within Okta, One Horizon Group, Vivopower International Plc, PetIQ, Quanterix, and Eidos Therapeutics  New Research Emphasizes Economic Growth",GlobeNewswire
